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Abstract
Biomaterial-associated infections constitute a major clinical problem that is difficult to treat and often necessitates implant
replacement. Pathogens can be introduced on an implant surface during surgery and compete with host cells attempting to
integrate the implant. The fate of a biomaterial implant depends on the outcome of this race for the surface. Here we
studied the competition between different bacterial strains and human U2OS osteoblast-like cells (ATCC HTB-94) for a
poly(methylmethacrylate) surface in the absence or presence of macrophages in vitro using a peri-operative contamination
model. Bacteria were seeded on the surface at a shear rate of 11 1/s prior to adhesion of U2OS cells and macrophages. Next,
bacteria, U2OS cells and macrophages were allowed to grow simultaneously under low shear conditions (0.14 1/s). The
outcome of the competition between bacteria and U2OS cells for the surface critically depended on bacterial virulence. In
absence of macrophages, highly virulent Staphylococcus aureus or Pseudomonas aeruginosa stimulated U2OS cell death
within 18 h of simultaneous growth on a surface. Moreover, these strains also caused cell death despite phagocytosis of
adhering bacteria in presence of murine macrophages. Thus U2OS cells are bound to loose the race for a biomaterial surface
against S. aureus or P. aeruginosa, even in presence of macrophages. In contrast, low-virulent Staphylococcus epidermidis did
not cause U2OS cell death even after 48 h, regardless of the absence or presence of macrophages. Clinically, S. aureus and P.
aeruginosa are known to yield acute and severe biomaterial-associated infections in contrast to S. epidermidis, mostly known
to cause more low-grade infection. Thus it can be concluded that the model described possesses features concurring with
clinical observations and therewith has potential for further studies on the simultaneous competition for an implant surface
between tissue cells and pathogenic bacteria in presence of immune system components.
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Introduction
Biomaterial-associated infection (BAI) is a serious problem in
modern medicine. BAI is often difficult to treat, as the biofilm
mode of growth protects infecting pathogenic microorganisms
against both the host defense system and antibiotics [1]. In most
cases, the final outcome is removal of the infected implant.
Biomaterial implants can become contaminated by microorgan-
isms in different ways. The best documented route is direct
contamination of the implant surface during surgery (peri-
operative contamination) or contamination during hospitalization
(post-operative contamination). Whether or not microbial con-
tamination eventually results in BAI, depends on the outcome of
the so-called ‘race for the surface’ between successful tissue
integration of the implant surface and biofilm formation [2]. If this
race is won by tissue cells, then the implant surface is covered by a
cellular layer and less vulnerable to biofilm formation. Alterna-
tively, if the race is won by bacteria, the implant surface will
become colonized by bacteria and tissue cell functions are
hampered by bacterial virulence factors and excreted toxins
[2,3]. Since microorganisms are frequently introduced on an
implant surface during surgery, microorganisms have a head start
in this race for the surface. In the concept of the race for the
surface, full coverage of an implant surface in vivo by a viable tissue
cell layer, intact cell membrane and functional host defense
mechanisms resists biofilm formation [4]. Especially in case of
orthopedic and dental implants, establishment of a robust interface
with fusion between biomaterial surface and bone tissue is
essential, requiring adhesion, proliferation and differentiation of
tissue cells for successful implantation.
Staphylococcus epidermidis and Staphylococcus aureus are the most
frequently isolated pathogens from infected biomaterials implant
surfaces [2,5]. Additionally isolated organisms include Escherichia
coli and Pseudomonas aeruginosa [2,5]. Almost 50% of the infections
associated with catheters, artificial joints and heart valves are
caused by S. epidermidis [6], whereas S. aureus is detected in
approximately 23% of infections associated with prosthetic joints
[6]. P. aeruginosa is the causative organism of approximately 12% of
hospital acquired urinary tract infections, 10% of bloodstream
infections and 7% of hip joint infections [7].
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determine the influence of peri-operative bacterial contamination on
the race for the surface, in which adhesion, spreading and growth of
U2OS osteosarcoma cells on a biomaterial surface are compared in
the absence or presence of adhering S. epidermidis [8]. The outcome of
the competition between contaminating S. epidermidis ATCC 35983
and U2OS cells on glass appeared to be dependent on the number of
bacteria adhering prior to U2OS cell seeding and the absence or
presenceoffluidflow.Cellslostthecompetitionintheabsenceofflow
conditions presumably due to accumulation of bacterial toxins, but
were able to grow under flow due to the continuous supply of fresh
medium to and removal of toxins from the interface on all commonly
used biomaterial surfaces included in that study [9].
In a healthy host, the host immune system comes to the aid of
tissue cells [10]. Macrophages are one of the most predominant
immune cells that arrive within minutes to hours at an implant site
and can remain at a biomaterial surface for several weeks to
orchestrate the inflammatory process and foreign body reactions
[10]. During infection, macrophages detect bacteria via cell
surface receptors that bind to bacterial ligands and opsonines [11–
13]. Subsequently, macrophages ingest pathogens and activate
cellular functions such as proliferation, secretion of proteins and
cytokines, and respiratory burst to destroy phagocytozed micro-
organisms and recruit other cells from the adaptive immune
system [11]. However, it has been shown that the presence of a
foreign body may impair the host immune system and conse-
quently low numbers of adhering bacteria can already be sufficient
to cause a BAI [14].
Bacterial virulence and alterations in the host defense including
macrophage recruitment, are contributing factors to the patho-
genesis of BAI [10], but hitherto have not been included in an
experimental model to study the race for the surface. Therefore
the aims of this study were to compare the influence of different
bacterial strains of S. epidermidis, S. aureus and P. aeruginosa in a peri-
operative contamination model on the outcome of the competition
for a poly(methylmethacrylate) (PMMA) surface between bacteria
and U2OS cells in the absence and presence of macrophages.
Results
Bacterial-U2OS cell interactions in absence of
macrophages
To compare the influence of different strains of S. epidermidis, S.
aureus and P. aeruginosa in a peri-operative contamination model on
the outcome of the competition for a PMMA surface between
bacteria and U2OS cells, bacteria were allowed to adhere prior to
U2OS cell adhesion and spreading. Subsequently, after 1.5 h of
static adhesion of U2OS cells, simultaneous growth of bacteria and
U2OS cells was allowed under flow at a shear rate of 0.14 1/s for a
period of 48 h. Immediately after seeding, U2OS cell adhesion
and spreading were observed using phase-contrast microscopy,
both in the absence and presence of adhering bacteria on PMMA.
At 1.5 h, the average number of adhering U2OS cells on the
PMMA surface was 2.5610
4 cells/cm
2 with an average area per
cell of 500 mm
2. The spreading of U2OS cells on the PMMA
surface at 1.5 h was not significantly different in the absence or
presence of adhering bacteria, regardless of whether S. epidermidis,
S. aureus or P. aeruginosa strains were involved. After 18 h of growth,
rounding up and detachment of U2OS cells, indicative of cell
death, was observed on PMMA in the presence of adhering S.
aureus and P. aeruginosa strains (Video S1), whereas no cell death
was observed in the presence of adhering S. epidermidis strains
(Figure 1A). Moreover, simultaneous growth of U2OS cells and S.
epidermidis was observed for a period of 48 h (Video S2).
After 48 h of growth, TRITC-Phalloidin staining of the U2OS
cells in combination with fluorescence microscopy was applied to
quantitatively measure cell number and surface coverage. In
Figure 1B, it can be seen that the number of adhering U2OS cells
was significantly reduced (p,0.01) in the presence of S. epidermidis
as compared to the control (no bacteria). The reduction in U2OS
cell adhesion after 48 h was larger (p,0.01) in the presence of S.
epidermidis 3399 and S. epidermidis ATCC 35984 compared to S.
epidermidis ATCC 35983 (p,0.05). Adhering U2OS cells showed
no significant difference in spreading per cell on PMMA in the
presence of adhering S. epidermidis as compared to the control
(Figure 1C).
In the concept of the race for the surface, the total surface
coverage of the substratum by tissue cells is considered
determinant for the fate of an implant. The coverage of the
surface by U2OS cells at 1.5 h after seeding and after 48 h of
growth are shown in Figure 1D. The surface coverage by adhering
U2OS cells, 1.5 h after seeding varied between 11% and 16%
regardless of the presence or absence of adhering bacteria. The
coverage of the surface by U2OS cells was significantly increased
after 48 h in the absence as well as in the presence of adhering S.
epidermidis. In the presence of adhering S. aureus and P. aeruginosa,
reductions in surface coverage by U2OS cells were observed after
18 h of growth (Figure 2), indicating U2OS cell death and no
U2OS cells could be detected on the PMMA surface after 48 h.
Bacterial-U2OS cell-macrophage interactions
To compare the influence of macrophages on the outcome of
the competition for a PMMA surface between bacteria (S.
epidermidis, S. aureus and P. aeruginosa) and U2OS cells, bacteria
were allowed to adhere to the biomaterial surface prior to U2OS
cell and macrophage adhesion. U2OS cells and macrophages were
allowed to grow simultaneously for 24 h. Events are illustrated as
follows:
Migration of macrophages towards bacteria and
phagocytosis. The number of bacteria adhering to the
PMMA surface prior to seeding of U2OS cells and macrophages
was set to 10
3 bacteria/cm
2. Subsequently, U2OS cells and
macrophages were allowed to adhere to the surface and the
simultaneous interactions between bacteria, macrophages and
U2OS cells were observed by phase-contrast microscopy. As an
example, Figure 3 shows macrophage migration in the presence of
U2OS cells towards adhering S. epidermidis ATCC 35983 and
subsequent phagocytosis. Macrophage migration towards bacteria
and phagocytosis was similar on PMMA colonized by S. epidermidis,
S. aureus and P. aeruginosa (data not shown).
Bacterial biofilm formation. Biofilm growth was assessed
over time by determining the numbers of bacteria adhering to
PMMA at different time points during the simultaneous growth of
bacteria, U2OS cells and macrophages (Figure 4) for one strain of
each of the three different bacterial species involved.
In the presence of macrophages, reductions in the numbers of
adhering S. epidermidis, S. aureus and P. aeruginosa were observed as
compared to absence of macrophages. This effect was seen up to
20 h of growth for S. epidermidis and up to 14 h and 10 h for S.
aureus and P. aeruginosa, respectively. Thereafter, macrophage burst
and release of ingested bacteria (predominantly alive) occurred.
U2OS cell adhesion and spreading. Immediately after
seeding, U2OS cell adhesion and spreading on PMMA was
observed, regardless of the presence or absence of macrophages.
After 24 h of simultaneous growth U2OS cell death was observed
in the presence of S. aureus and P. aeruginosa biofilms irrespective of
the absence or presence of macrophages (Video S3). Alternatively,
colonizing S. epidermidis did not significantly affect U2OS cells and
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presence of macrophages (see Figure 5).
Discussion
This paper presents the first experimental in vitro model to study
the influence of different pathogens on the outcome of the race
between adhering bacteria and tissue cells for a biomaterial surface
in the absence and presence of macrophages. In the model,
bacteria were allowed to adhere prior to cell adhesion and
spreading, which mimics the situation of peri-operative bacterial
contamination of implant surfaces. The number of bacteria
adhering on the PMMA surface prior to initiating U2OS cell
adhesion and spreading was set to 10
3 bacteria/cm
2. Alternatively,
we could have set the time allowed for bacterial contamination to
occur as a constant, but this would have introduced the different
abilities of the strains to adhere and grow into a biofilm into the
study as an additional variable, which we wanted to avoid. In the
past, it has been documented that during a surgical procedure of
1 h, the total number of bacteria carrying particles, falling on
the wound is about 270 bacteria/cm
2 [15]. These numbers are
generally higher during periods of activity and when more people
are present in the operation theatre [15]. More recent, through the
use of modern, better ventilated operation theatres (20 changes of
air per hour) and impermeable patient and personnel clothing,
peri-operative bacterial contamination may be less [16]. However,
many surgical procedures in which implants are introduced in
the body last longer than 1 h. Therefore, the level of bacterial
Figure 1. Simultaneous growth of bacteria and U2OS cells under flow. A) Phase contrast images of U2OS cells after 18 h of growth in the
presence of adhering bacteria (a – control, b – S. epidermidis ATCC 35983, c – S. aureus ATCC 12600 and d – P. aeruginosa ATCC 27853) on PMMA
surfaces. In Fig. 1A-b, U2OS cells are differentiated by a contour line from S. epidermidis biofilm. White arrows in Figs. 1A-c and 1A-d indicate U2OS cell
death. The bar denotes 20 mm. B) Percentage change in the number of adhering U2OS cells after 48 h of growth with respect to their initial number
immediately after seeding at 1.5 h on PMMA in the absence (no bacteria) and presence of adhering bacteria. Error bars represent the standard
deviations over three replicates, with separately cultured bacteria and osteoblast-like cells. For S. aureus and P. aeruginosa the error bars are zero,
since all percentage change in adhering numbers of U2OS cells were 100%. Cell number in the presence of bacteria is significantly different (p,0.01)
from the cell number in the absence of bacteria. C) Average area per adhering U2OS cell immediately after seeding at 1.5 h (light blue) and after 48 h
(dark blue) of growth on PMMA in the absence (no bacteria) and presence of adhering bacteria. Error bar represents the standard deviation over
three replicates, with separately cultured bacteria and osteoblast-like cells. Average area by U2OS cells after 48 h in the presence of adhering bacteria
(S. aureus and P. aeruginosa) is significantly different (p,0.05) from the absence of bacteria. D) Surface coverage by adhering U2OS cells immediately
after seeding at 1.5 h (light blue) and 48 h (dark blue) of growth on PMMA in the absence (no bacteria) and presence of adhering bacteria. Error bar
represents the standard deviation over three replicates, with separately cultured bacteria and osteoblast-like cells. Surface coverage by U2OS cells
after 48 h in the presence of adhering bacteria are significantly different (p,0.05) from the absence of bacteria.
doi:10.1371/journal.pone.0024827.g001
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PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24827Figure 2. Surface coverage of U2OS cells as a function of time. An example of surface coverage by adhering U2OS cells as a function of time
on PMMA in the presence of adhering bacteria ((m)–S. epidermidis 3399, (&)–S. aureus A20734, (N)–P. aeruginosa DN 7348).
doi:10.1371/journal.pone.0024827.g002
Figure 3. Macrophage migration towards S. epidermidis and phagocytosis under flow. Phase-contrast images of macrophage activity
toward S. epidermidis ATCC 35983 on a PMMA surface in the presence of U2OS cells: macrophage migration towards S. epidermidis (images 1–5),
bacterial clearance by phagocytosis (images 6–7) and further migration (images 8–12). The bar denotes 50 mm.
doi:10.1371/journal.pone.0024827.g003
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Due to these low numbers, peri-operatively introduced organisms,
particularly when of low virulence, can survive on an implant
surface for prolonged periods of time and later, during periods of
host immune depression, proliferate and establish an infection with
clinical symptoms [17].
The pathogenesis of BAI is complex and depends on factors
such as bacterial virulence, physico-chemical properties of the
biomaterial surface and alterations in the host defense [14].
Previously, in our model for the competition between S. epidermidis
and U2OS osteoblast-like cells, all common biomaterial surfaces,
including PMMA, allowed S. epidermidis ATCC 35983 biofilm
formation with a negative impact on the coverage of the
biomaterial surface by U2OS cells, although cells survived for at
least 48 h [9]. Yet, PMMA showed better cell adhesion and
spreading in the presence of adhering S. epidermidis ATCC 35983
than other commonly used biomaterials [9]. Our present study
supports previous observations that U2OS cells are able to adhere,
spread and grow in the presence of slime producing S. epidermidis
strains, and extends these observations to the absence and
presence of macrophages. Macrophages prolong the time that
U2OS cells can survive an attack by adhering S. aureus and P.
aeruginosa. However, it was observed that adhering S. aureus and P.
aeruginosa cause death of all adhering U2OS cells and macrophages
within 24 h. These observations are in line with clinical findings
that BAI due to S. aureus and P. aeruginosa usually progresses much
more aggressively than BAI caused by S. epidermidis. Buchholz and
co-workers [18] showed that 54 of 64 patients (84%) with an
infection by a low-virulent organism were free from infection 2
years later. Alternatively, when S. aureus was the causative
Figure 4. Restriction of bacterial biofilm growth by the presence of macrophages. The numbers of adhering bacteria on PMMA as a
function of time during the simultaneous growth of bacteria and U2OS cells in the absence and presence of macrophages in a parallel plate flow
chamber: S. epidermidis ATCC 35983 in the absence (%) and presence of macrophages (&), S. aureus ATCC 12600 in the absence (#) and presence of
macrophages (N), P. aeruginosa ATCC 27853 in the absence (n) and presence of macrophages (m).
doi:10.1371/journal.pone.0024827.g004
Figure 5. Adhesion and spreading of U2OS cells in the presence of macrophages. Phase-contrast images of adhering U2OS cells to PMMA
after 24 h of simultaneous growth of bacteria (S. epidermidis ATCC 35983, S. aureus ATCC 12600 and P. aeruginosa ATCC 27853) and U2OS cells in the
absence (upper images) and presence (lower images) of macrophages. Macrophages are orange-stained. The bar denotes 50 mm.
doi:10.1371/journal.pone.0024827.g005
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almost 50% of the patients with a Gram-negative bacterial
infection (Pseudomonas) experienced recurrent infection [18]. S.
aureus appears more frequently in acute infections within 4 weeks
after surgery of complicated total joint arthroplasty than does S.
epidermidis. S. epidermidis is most commonly implicated in delayed
septic loosening of total joint prostheses [19] or even in presumed
aseptic loosening [20], indicating its low virulence with only
minor clinical symptoms of infection [20]. This suggests a direct
correlation between the clinical outcome and the causative bac-
terial strain, in line with our in vitro results. Overloading the system
with a higher concentration of macrophages would eventually
yield clearance of all adhering bacteria from the substratum
surface in favor of U2OS cell adhesion and spreading, but
considering the direct correlation existing between clinical
outcome and the causative bacterial strain, we believe the current
macrophage concentration to be most suitable for achieving the
aim of this study, i.e. comparing the influence of different strains
on the race for the surface.
The slime substance produced by P. aeruginosa along with other
factors e.g. exotoxin A, exoenzyme S, elastase or alkaline protease
accounts for the particular virulence of Pseudomonas in implant
infections [7,21]. Pseudomonas slime injected into mice produces
liver and renal dysfunction and death within a short time, while no
such effect is seen with S. epidermidis slime [21,22]. In vascular
grafts, pacemakers and orthopedic devices, S. epidermidis is mostly
found in low-grade infections and a common cause of late
infections. In patients with low-grade hip implant infections, only
5% of the patient had a temperature of 37.8uC or higher and only
20% had prolonged wound leakage [23]. The low virulence of S.
epidermidis strains compared to S. aureus or P. aeruginosa is due to the
lack of additional genes responsible for producing severely tissue
damaging toxins [6,7,24]. In S. epidermidis infections, biofilm
formation is considered the only virulence factor and therefore
infections are usually sub-acute or chronic [25–27].
In general, immune cells migrate, engulf and kill invading
microorganisms [28–30]. A previous study on the interaction
between macrophages and colonizing S. epidermidis, showed that
macrophage behavior is surface dependent [31]. Macrophage
migration towards bacteria and phagocytosis was enhanced on
highly hydrated, cross-linked poly(ethylene)-glycol (PEG) based
polymer coatings compared to uncoated substrata due to the weak
adhesion of macrophages and bacteria to the PEG coating [31].
On PMMA, we also see macrophages migrate towards adhering
bacteria and engulf them. The degree of phagocytosis of adhering
bacteria by macrophages differed depending on the virulence of
the bacterial strain. In the presence of low-virulent S. epidermidis,
bacterial biofilm growth was strongly reduced by the presence of
macrophages up to 20 h compared to reductions lasting only 14 h
and 10 h in the case of highly virulent S. aureus and P. aeruginosa
biofilms, respectively. Furthermore, we observed that after a
certain period of time, macrophages became exhausted and broke
open which led to release of their bacterial content. Similarly,
Kubica et al. [32] clearly showed that intracellular S. aureus can
survive within human macrophages several days until a point
where bacteria escaped the intracellular confinement, proliferated
in the conditioned medium and killed the cells. Garzoni et al. [33]
indicated that some coagulase-negative staphylococci could
promote infection by intracellular colonization.
Several studies have demonstrated in line with the current
results that immune cells may indeed lose their ability to kill
bacteria in the presence of a biomaterial [30,34,35,36]. Neutro-
phils exhibited decreased bactericidal activity and reduced
superoxide production in the presence of extracellular slime
producing S. epidermidis [37–41], while phagocytozed S. aureus
suppressed the production of superoxide inside macrophages [36].
In a murine model, high numbers of S. epidermidis could not only
persist within macrophages in peri-catheter tissue without showing
any signs of inflammation [14], but were also able to proliferate.
Macrophages in the periphery of a biomaterial in vivo showed
deficient intracellular killing of pathogens, resulting in a compro-
mised local host defense [14]. In vivo, bacteria may well survive
inside the macrophages for prolonged periods of time. These
bacteria will favor the development of BAI, especially when the
physical condition of a patient disturbs the balance between
bacteria and the host response [14].
The influence of macrophages described here on the compe-
tition between bacteria and tissue cells to colonize and integrate a
biomaterial surface is novel. It is demonstrated that despite the
presence of macrophages, U2OS cells loose the race for the surface
in the presence of highly virulent S. aureus or P. aeruginosa, while
cells can survive at least 48 h in the presence of S. epidermidis,
regardless of the absence or presence of macrophages.
These results clearly bear features concurrent with clinical
observations and therewith the model described, including the
bacterial and macrophage densities used and the use of an
immortal human cell line derived from osteosarcoma cells, has
great potential to study the simultaneous competition for an
implant surface between tissue cells and bacteria in the presence of
immune system components.
Materials and Methods
Biomaterial
Poly(methyl methacrylate) (PMMA) (Vink Kunststoffen, Didam,
The Netherlands) was used as a substratum. Samples were rinsed
thoroughly with ethanol (Merck, Darmstadt, Germany) and
washed with sterile ultrapure water before use to yield a water
contact angle of 7363 degrees [9].
Osteoblast-like cell culturing and harvesting
U2OS osteoblast-like cells, an immortal human cell line derived
from osteosarcoma cells, were chosen for this study because of
their ease of growth, although we realize that cancer cell lines may
not represent all aspects of in vivo cell behavior and possibly differ
in integrin expression, with an impact on their adhesion to
fibronectin-coated biomaterials. U2OS osteosarcoma cells (ATCC
number: HTB-96; obtained from LGC standards, Wesel,
Germany) [8] are routinely cultured in Dulbecco’s modified
Eagles Medium (DMEM)-low glucose supplemented with 10%
fetal calf serum (FBS), 0.2 mM ascorbic acid-2-phosphate (AA2P),
denoted in the paper as ‘‘DMEM+FBS’’. Cells were maintained at
37uC in a humidified atmosphere with 5% CO2, and were
passaged at 70–90% confluency using trypsin/ethylenediamine-
tetraacetic acid. The harvested cells were counted using a Bu ¨rker-
Tu ¨rk haemocytometer and subsequently diluted to a concentra-
tion of 6610
5 cells/ml.
Macrophages culturing and harvesting
J774A.1 murine macrophages (ATCC number: TIB-67;
obtained from LGC standards, Wesel, Germany) were routinely
cultured in DMEM-high glucose supplemented with 10% FBS
and denoted in the paper as ‘‘optimal medium’’. Macrophages
were maintained at 37uC in a humidified atmosphere with 5%
CO2, and passaged at 70–80% confluency by scraping. The
harvested cells were counted using a Bu ¨rker-Tu ¨rk haemocytom-
eter and subsequently diluted to a concentration of 12610
5 cells/
ml. The macrophage J774A.1 was chosen because this cell line
In Vitro Model for BAI Pathogenesis
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substratum surface.
Bacterial growth conditions and harvesting
The bacterial strains used in this study were S. epidermidis ATCC
35983, S. epidermidis ATCC 35984, S. epidermidis 3399 (isolated
from skin), S. aureus ATCC 12600, S. aureus A20734 (isolated from
an infected abdominal mesh), S. aureus 7388 (isolated from an
infected joint prosthesis), P. aeruginosa DN7348 (isolated from an
infected joint prosthesis), P. aeruginosa PA01 (clinical isolate from
burn wound), P. aeruginosa ATCC 27853. All S. epidermidis strains
used were slime producing, as indicated by a Congo-red agar assay
(see Table S1). First, a strain was streaked on a blood agar plate
from a frozen stock and grown overnight at 37uC. The plate was
then kept at 4uC. For each experiment, a colony was inoculated in
10 ml of tryptone soya broth (TSB; OXOID, Basingstoke,
England) and cultured for 24 h. This culture was used to inoculate
a second culture, which was grown for 17 h prior to harvesting.
Bacteria were harvested by centrifugation at 50006g for 5 min at
10uC and washed twice with sterile ultrapure water. Subsequently,
the harvested bacteria were sonicated on ice (3610 s) in sterile
potassium phosphate buffer (PBS, 10 mM potassium phosphate,
0.15 M NaCl, pH 7.0) in order to break bacterial aggregates. This
suspension was further diluted in sterile PBS to a concentration of
3610
6 bacteria/ml. Prior to the experiments, growth and biofilm
formation of all bacterial strains in modified culture medium (98%
DMEM+FBS and 2% TSB [8]) was confirmed by culturing
bacteria in this medium for 48 h.
Ethics statement
Cell lines used in this study were obtained from LGC standards,
Wesel, Germany.
Competitive assay for U2OS cell growth and biofilm
formation
The competitive assay was performed on the PMMA bottom
plate of a parallel plate flow chamber (17561760.75 mm
3), as
described in detail before [8]. The flow chamber was equipped
with heating elements and kept at 37uC throughout the
experiments. Bacterial and U2OS deposition were observed with
a CCD camera (Basler AG, Germany) mounted on a phase-
contrast microscope Olympus BH-2 (Olympus, Germany) with a
406objective for bacteria and 106objective for U2OS cells.
Prior to each experiment, all tubes and the flow chamber were
filled with sterile PBS, taking care to remove all air bubbles from
the system. Once the system was filled, and before the addition of
the bacterial suspension, PBS was allowed to flow through the
system at a shear rate of 11 1/s. Then, a bacterial suspension in
PBS was perfused through the chamber at the same shear rate and
phase-contrast images were obtained. As soon as the desired
density of adhering bacteria (10
3 bacteria/cm
2), was reached, flow
was switched to sterile PBS to remove the bacterial suspension
from the tubes and chamber. Subsequently, a U2OS cell
suspension (6610
5 cells/ml) in modified culture medium was
allowed to enter the flow chamber. Once the entire volume of
buffer inside the chamber was replaced by the cell suspension, flow
was stopped for 1.5 h in order to allow U2OS cells to adhere and
spread on the substratum surface. Subsequently, phase contrast
images (nine images, 9006700 mm each) were taken and the
number of adhering cells per unit area as well as the area per
spread cell were determined using Scion image software. Finally,
modified culture medium supplemented with 2% HEPES was
perfused through the system at a shear rate of 0.14 1/s for 48 h
and phase-contrast images were obtained every 30 min. Biofilm
growth was assessed in real-time by determining the numbers of
adhering bacteria per unit area using proprietary software based
on the Matlab Image processing Toolkit (The MathWorks, MA,
USA).
Fluorescence staining and determination of material
surface coverage with U2OS cells
After 48 h of flow, the surfaces were prepared for fluorescence
staining to assess cell number and surface coverage. Phase
contrast images could not be used for quantification because the
images were too crowded after 48 h and the spread area per cell
was difficult to determine. For fixation, surfaces with adhering
bacteria and U2OS cells were placed in a Petri dish with 30 ml of
3.7% formaldehyde in cytoskeleton stabilization buffer (CS;
0.1 M Pipes, 1 mM EGTA, 4% (w/v) polyethylene glycol 8000,
pH 6.9). After 5 min, the fixation solution was replaced by 30 ml
fresh CS for another 5 min. Subsequently, U2OS cells were
incubated in 0.5% Triton X-100 for 3 min, rinsed with PBS and
stained for 30 min with 5 ml PBS containing 49 ml DAPI and
2 mg/ml of TRITC-phalloidin and the U2OS cells on the
surfaces were washed four times in PBS. DAPI will stain the
nucleus blue, while TRITC-phalloidin stains the actin cytoskel-
eton in red. Images (nine images on different locations,
9006700 mm each) were taken with a confocal laser scanning
microscopy (Leica DMRXE with confocal TCS SP2 unit). The
images were analyzed using Scion image software and the
number of adhering U2OS cells per unit area and the average
area per spread cell were determined. The total coverage of the
substratum surface by U2OS cells was calculated from the
number of cells and the spread area.
Competitive assay for U2OS cell growth and biofilm
formation in the presence of macrophages
The competition between bacteria and U2OS cells for the
colonization of PMMA in the presence of macrophages was
assessed on the PMMA for one strain of each of the three different
bacterial species involved, roughly according to the above
procedure with some minor modification.
As soon as the desired density of adhering bacteria (10
3
bacteria/cm
2), was reached and flow was switched to sterile PBS, a
cell suspension consisting of U2OS cells (6610
5 cells/ml) and
J774A.1 macrophages (12610
5 cells/ml) in optimum medium was
added to the flow chamber. Once the entire volume of buffer
inside the chamber was replaced by the cell suspension, flow was
stopped for 1.5 h in order to allow U2OS cells and macrophages
to adhere and spread on the substratum surface. Ultimately,
optimal medium supplemented with 2% HEPES was perfused
through the system at a shear rate of 0.14 1/s for 24 h and phase-
contrast images were obtained continuously at 2 min intervals.
Biofilm growth was assessed in real-time by determining the
numbers of adhering bacteria per unit area.
At the end of the assay, surfaces were prepared for qualitative
analysis to assess U2OS cell and macrophage shape and spreading.
Cells adhering to PMMA were fixed with citrated-acetone-
formaldehyde fixative solution for 30 s and stained with an
alkaline-dye mixture (Sigma-Aldrich, Germany) (Naphtol AS-BI
phosphate, sodium nitrite, fast blue BB base) for 15 min. Samples
were subsequently rinsed with demineralized water and counter-
stained for 2 min with neutral red solution. Then the samples were
rinsed once again with demineralized water, allowed to dry and
phase-contrast images were taken on different places of the
sample. Differentiated U2OS osteosarcoma cells stained purple/
In Vitro Model for BAI Pathogenesis
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24827blue (alkaline phosphatase-positive) and macrophages were orange
stained.
Statistics
Data are presented as a mean with standard deviation.
Statistical ANOVA analysis was performed followed by a Tukey’s
HSD post-hoc test and p,0.05 was considered significant.
Supporting Information
Table S1 Slime production by the S. epidermidis strains
used in this study on Congo-red agar. Slime producing
strains appear as dark black colonies. S. epidermidis ATCC 12228
was included as a negative control, not producing any slime and
appeared as pink colonies.
(TIF)
Video S1 Simultaneous growth of S. aureus ATCC 12600
and U2OS cells on PMMA surface for 48 h.
(WMV)
Video S2 Simultaneous growth of S. epidermidis ATCC
35983 and U2OS cells on PMMA surface for 48 h.
(WMV)
Video S3 Simultaneous growth of S. aureus ATCC 12600
and U2OS cells in the presence of macrophages on
PMMA surface for 24 h.
(WMV)
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